Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
GSK | London | GBP | Real-time | |
GSKl | BATS Europe | GBP | Delayed | |
GSK | NYSE | USD | Real-time | |
GLAXF | OTC Markets | USD | Delayed | |
GSKN | Mexico | MXN | Delayed | |
GS70y | Frankfurt | EUR | Delayed | |
GS71 | TradeGate | EUR | Delayed | |
GS71 | Frankfurt | EUR | Delayed | |
GS71 | Xetra | EUR | Delayed | |
GSKm | Buenos Aires | ARS | Delayed | |
G1SK34 | B3 | BRL | Delayed |
GSK plc reported earnings results for the second quarter and six months ended June 30, 2024. For the second quarter, the company reported sales was GBP 7,884 million compared to GBP 7,178 million a year ago. Net income was GBP 1,173 million compared to GBP 1,624 million a year ago. Basic earnings per share from continuing operations was GBP 0.288 compared to GBP 0.401 a year ago. Diluted earnings per share from continuing operations was GBP 0.285 compared to GBP 0.397 a year ago.For the six months, sales was GBP 15,247 million compared to GBP 14,129 million a year ago. Net income was GBP 2,219 million compared to GBP 3,114 million a year ago. Basic earnings per share from continuing operations was GBP 0.545 compared to GBP 0.769 a year ago. Diluted earnings per share from continuing operations was GBP 0.539 compared to GBP 0.762 a year ago.
Period Ending: | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
---|---|---|---|---|
Total Revenue | 7884 | 7363 | 8052 | 8147 |
Gross Profit | 5822 | 5448 | 5237 | 5904 |
Operating Income | 2215 | 2247 | 1639 | 2556 |
Net Income | 1173 | 1046 | 350 | 1464 |
Period Ending: | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
---|---|---|---|---|
Total Assets | 58066 | 58511 | 59005 | 60862 |
Total Liabilities | 44296 | 45282 | 46210 | 48243 |
Total Equity | 13770 | 13229 | 12795 | 12619 |
Period Ending: | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 1113 | 958 | 3196 | 2212 |
Cash From Investing Activities | 770 | -149 | 268 | -491 |
Cash From Financing Activities | -1584 | -1060 | -3592 | -1762 |
Net Change in Cash | 291 | -270 | -162 | -18 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review